About
Research Library
Company Pages
Allergy Therapeutics
Futura Medical
HUTCHMED
MaxCyte
Mereo BioPharma
Nexstim
Redx Pharma
Scancell
Contact
More Company News
Nexstim
Final results of successful rights issue
07 Apr 2021
Read More
Nexstim
Update on promising MDD treatment results
12 Mar 2021
Read More
Nexstim
Subscription rights issue of €6.6m
08 Mar 2021
Read More
Nexstim
Two new NBS orders in Norway & US
04 Mar 2021
Read More
Nexstim
Encouraging results from initial pilot study in severe depression
03 Mar 2021
Read More
Nexstim
FY20 financial statements
26 Feb 2021
Read More
Nexstim
German University Hospital orders NBS System with NexSpeech
28 Jan 2021
Read More
Nexstim
New study presents impressive results of SmartFocus nTMS Language Mapping
13 Jan 2021
Read More
Nexstim
Three new NBS System orders
22 Dec 2020
Read More
Nexstim
Annulment of stock options held by Nexstim
15 Dec 2020
Read More
1
2
3
4
…
10
Return to Nexstim
© 2019-21 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).
About
Research Library
Company Pages
▼
Allergy Therapeutics
Futura Medical
HUTCHMED
MaxCyte
Mereo BioPharma
Nexstim
Redx Pharma
Scancell
Contact